$695 | Single User
$2850 | Site License
$5650 | Global License

Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs)
[Published by FirstWord Pharma]

Published by FirstWord Pharma: 01 Nov 2013 | 81 | In Stock

Introduction

Introduction


There’s a revolution happening...and it’s going to change the way pharma thinks.



As the accountable care movement gains traction in the United States and physicians eye a possible trillion in saved healthcare costs, ACOs are emerging quickly. There is no question that knitting together improved quality of care, real world data and quality measures will result in lower healthcare expenditures. But how will that affect pharma?



The answer lies in being a first-mover, understanding what it takes to be a successful ACO and most of all, adjusting traditional marketing and development practices in response. To be agile in the face of revolution, pharma must first understand the complete scope of the change now underway.



In Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs), FirstWord explores the rapidly changing landscape of the accountable care movement and how it is poised to impact pharma. The report examines the types of ACOs, the critical pathway to their success and why it’s so important for pharma to switch marketing and development practices to meet their needs. As an overview of a movement that changes minute-by-minute, the report is an urgently needed snapshot of an industry in transition.


Scope


Key Report Features of Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs) include:


  • Up-to-date overview of the accountable care movement, ACO types and keys to their success

  • Analysis of why pharma must review marketing and development practices to meet ACO needs

  • Discussion of how accountable care varies from managed care

  • Examination of the relationship between quality measures and savings

  • Analysis of gaps facing ACOs, with particular attention to where pharma can direct their efforts

  • Puchase Reasons


    Key Benefits


    Because accountable care is still evolving, there is an urgent need to stay up to date with changes as they happen. Amongst the many benefits in Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs), this report will help you to:


  • Understand the scope and nature of the changes being wrought

  • Learn which ACO data requirements can be fulfilled by pharma

  • Understand the parameters of guidelines governing ACOs

  • Develop key knowledge in how to redirect efforts in the chronic disease market to be more patient-centric

  • Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs) answers key questions:


  • What do pharma companies need to do to market their products to ACOs?

  • What data do ACOs require?

  • Are there functional gaps facing ACOs?

  • How can pharma better support patients?

  • What should pharma do to get into the conversation about improving population management?

  • Highlights


    Key facts


  • Americans spend .8 trillion on healthcare—enough to buy the ten most valuable companies in the US, host three Olympic Games and still have more money than Warren Buffet. Possible savings from ACOs may reach trillion of that.

  • Since its inception, the ACO movement has attracted considerable interest from federally funded and private sector insurers.

  • There are more than double the number of ACOs today than there were in June 2012.

  • Content Highlights



    The accountable care movement is emerging rapidly. In this report, you will discover:


  • How ACOs and pharma will need to work together in the future

  • The technical hurdles facing ACOs

  • The true scope of quality measures required of ACOs and how pharma may play a role
  • Table of Contents
    for Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs) [Published by FirstWord Pharma]

    • 1.Executive summary

      2.Introduction

      2.1.Constraining costs

      2.2.Creating the conditions for assessing value

      2.3.PPACA impact on pharma

      3.The ACO movement

      3.1.Accelerating factors

      3.1.1.Enormous potential savings

      3.1.2.High cost differentials

      3.2.Linking data

      3.2.1.Rapid pace of change

      3.3.Working with real world data

      4.Different kinds of ACO

      4.1.Pharmacists enter the fray

      4.2.Diversification

      4.3.Medicare Shared Savings Programme

      4.4.Quality measures

      4.4.1.Who can take part in an ACO?

      4.4.2.Governance arrangements

      4.5.Catering for differences

      4.6.Commercial ACOs

      4.6.1.Choice of risk-sharing deals

      5.ACO implications for pharma

      5.1.So many variables

      5.2.Learning from the pioneers

      5.2.1.Getting real

      5.2.2.Other key learnings

      5.2.3.Early lessons from the private sector

      5.3.Broader dialogue becomes imperative

      5.4.New ways of thinking

      6.A transitional phase

      6.1.Filling the ACO capability gaps

      6.2.Coordinated care

      6.3.How can drugs reduce overall costs?

      6.4.Information to educate patients

      6.5.Optimising medication therapy

      6.6.The role of pharmacists in ACOs

      6.7.New stakeholders

      6.7.1.extenders

      6.7.2.Developing a patient focus

      6.7.3.Physicians require help

      6.8.Patient-centred disease management

      6.8.1.Data mining

      6.9.Population health management

      6.9.1.Pharma collaborations

      6.9.2.Care4Today

      7.Learning from the new NHS

      7.1.Global trends

      8.Issues of trust

      9.A marriage of health outcomes and profits

      10.Gearing up for change

    Additional Details

    Publisher

    FirstWord Pharma

    Publisher Information

    Reference

    81 |

    Number of Pages

    71

    Report Format

    PDF

    FirstWord Pharma Reports

    Related Reports

    TitleDate PublishedPrice fromMore Details
    Pharma and the mHealth Revolution - engaging with mobile-enabled physicians and HCPs
    IntroductionIt’s time to click on this.The media’s dubbed them ‘a doctor in your pocket’ and ‘health...
    01 Feb 2013 by FirstWord Pharma USD $695 More Info
    Big Data in Pharma Marketing
    IntroductionBig data - the huge volume of digital data generated worldwide - continues to grow expon...
    01 Jan 2013 by FirstWord Pharma USD $695 More Info
    Social and Mobile Pharma - the State of the Digital Landscape
    IntroductionTightly-regulated and conservative in outlook, the pharmaceutical industry has largely b...
    01 Nov 2012 by FirstWord Pharma USD $695 More Info
    Pharma and Payers – Building Better Relationships
    IntroductionChanges in the healthcare landscape have put payers (public and private) under mounting ...
    01 Sep 2012 by FirstWord Pharma USD $695 More Info
    Pharma Reputations: Managing Perceptions
    IntroductionPharma is no stranger to the idea of nurturing and defending corporate reputations. But...
    01 Aug 2012 by FirstWord Pharma USD $645 More Info
    Pharma's Future Role in CME
    IntroductionOver the last 10 years, every aspect of continuing medical education (CME) has endured m...
    01 Aug 2012 by FirstWord Pharma USD $695 More Info
    Pharma sales force shape, size and structure — where next?
    IntroductionRetarget your sales force with new resourcesSales force management now plays a critical ...
    01 Jul 2012 by FirstWord Pharma USD $695 More Info
    Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma
    IntroductionIn 2009, China’s government announced plans to invest RMB1.13 trillion (0 billion) in...
    01 Jun 2012 by FirstWord Pharma USD $995 More Info
    Meeting KOL Needs: What Pharma Needs to Know
    IntroductionThe role of the Key Opinion Leader (KOL) has changed over the past 30 years. And it's ab...
    01 Feb 2012 by FirstWord Pharma USD $1,445 More Info
    Academic Detailing: Pharma Fights Back
    IntroductionEver since it was introduced three decades ago, academic detailing—which now increasingl...
    01 Jan 2012 by FirstWord Pharma USD $745 More Info

    This report is published by FirstWord Pharma

    Download Free Report Summary PDF

    Pharma and the Changing US Payer Environment: Meeting the demands of Accountable Care Organizations (ACOs) [Published by FirstWord Pharma] | Download PDF Summary

    Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

    Ordering Information

    Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

    Accepted Card Types

    Payment

    Buy now using our secure payment system.

    We Stock...